Ref. No. : 63557699   
Abacavir Tenders, Acarbose Tab Tenders, Acarbose Tablet Tenders, Aceclofenac Gel Tenders, Aceclofenac Oint Tenders, Aceclofenac Paracetamol Bolus Tenders, Aceclofenac Paracetamol Tab Tenders, Aceclofenac Plus Paracetamol Tab Tenders, Acetaminophen Tenders, Acetaminophen Capsule Tenders
Anti Viral - NRTI Tenders, Antidiabetic- Type – 2 Tenders, Drug Tenders
Company Name : Can be viewed by Subscribers
Product Detail : Open House Drug Discount Agreements Dornase Alfa (deoxyribonuclease), Atc R05cb13
Tender Detail : Contract notice: open house drug discount agreements dornase alfa (deoxyribonuclease), atc r05cb13 See description of procurementit is not an open procedure, but a so-called open-house model! the form for the open procedure is only used because there is no form for the open-house model. contracts that are concluded in the open-house model are not subject to public procurement law due to the lack of a selection decision. the use of this form is not associated with submission to public procurement regulations. the aok bayern intends to enter into non-exclusive discount agreements with all interested pharmaceutical companies for the active substance dornase alfa (deoxyribonuclease), atc r05cb13, according to § 130a para. 8 sgb v to close. aok bayern offers all interested pharmaceutical companies that meet the eligibility requirements listed below the opportunity to conclude identical and non-individually negotiable discount agreements. the earliest possible start of the contract is october 1st, 2023, all contracts end on september 30th, 2025. a contract can be concluded at any time during this period, but no later than august 5th, 2025. the contracts can be terminated with one months notice to the end of the month. when a nationwide or state-specific discount contract for drugs with the active substance that is the subject of the order comes into force, the open-house agreements automatically expire for the corresponding term. a contract is concluded with all interested pharmaceutical companies that prove their suitability by completing and signing a self-declaration of reliability power of attorney) to submit the contract along with the completed and signed annex specification of the contractual medicinal products as well as the completed and signed self-declaration of reliability. the documents can either be signed in writing by hand or submitted electronically with a qualified electronic signature. hand-signed documents in writing are in 2 - to be sent in duplicate in the original to the following address: aok bayern - die gesundheitskassevergabestelle sgb vze25open-house discount contractscarl-wery-str. 2881739 munich electronic documents with a qualified electronic signature are to be submitted via the communication area in the procurement portal www.Dtvp.De. if complete and correct documents are received by the 5th of each month, the contract begins on the first of the following month, otherwise on the first of the following month but one. in the case of documents signed by hand in writing, the complete, completed and signed documents must be sent in advance by fax (089/62730650151), as a scan to the e-mail address vergabestelle1@by.Aok.De or via the communication area in the procurement portal www. dtvp.De observing the deadline if the complete and correct original documents in paper form are received by the 10th of the month at the aok bayern, award office pharmaceutical companies can apply for the activation of the tender documents in the
Tender Location : Not Classified - Turkey
Document Path : Can be viewed by Subscribers
Tender Closing Date : 5/08/2025 at 00:00 Hrs.
Tender Opening Date : 5/08/2025 at 12:00 Hrs.
Address : Can be viewed by Subscribers
Sub-Industry/Industry : Non Classified - Non Classified   
Essential Product,Face,Mask,Sanitizers,Gloves etc.
Members/Visitors Login to continue
 Email Id:

 Forgot Password?